Welcome to our dedicated page for Nephros news (Ticker: NEPH), a resource for investors and traders seeking the latest updates and insights on Nephros stock.
Nephros Inc. reports developments in water technology for medical and commercial markets, with emphasis on point-of-use filtration, waterborne pathogen risk reduction, and water management support. Company news commonly covers quarterly financial results, programmatic revenue trends, service offerings, customer education, and product adoption across healthcare facilities and other complex buildings.
Updates also include expansions of Nephros' water safety capabilities, regional market initiatives, and the Nephros Water Institute, an education effort focused on water quality, infection prevention, regulatory readiness, and emergency preparedness for compromised water events.
Nephros (Nasdaq: NEPH) reported Q1 2026 results: net revenue $5.2M (up 7% YoY) and net income $0.14M. Core programmatic revenue rose 23% YoY. Gross margin fell to 57% from 65% due to tariffs, FX headwinds, and revenue mix shifts. Cash was ~$4.0M; company remains debt free.
Nephros (Nasdaq: NEPH) will file first-quarter 2026 financial results on Thursday, May 7, 2026 after market close and will host a conference call the same day at 4:30 PM ET.
Dial-in numbers, an audio archive on the Nephros investor relations page, and a replay available through May 14, 2026 (replay code 1329051) were provided.
Nephros (Nasdaq: NEPH) is expanding its Greater New York market focus by hiring Dana Cunningham as a dedicated regional sales leader, effective April 16, 2026. The company cites a $25 million annual addressable opportunity for point-of-use filtration and related services in the region.
Cunningham will target healthcare systems, commercial facilities, and channel partners to accelerate adoption of Nephros’ filtration solutions amid aging infrastructure, heightened regulatory focus, and elevated waterborne pathogen risk.
Nephros (Nasdaq: NEPH) announced an expansion of customer-facing water-safety services on April 1, 2026, after Brianne McGuire earned the ASSE 12080 Legionella Water Safety and Management Specialist certification.
The company will now offer consultative Water Management Program (WMP) development services alongside filtration product installations, training and public education, and expects the capability to add customer value and a chargeable consulting revenue stream.
Nephros (Nasdaq: NEPH) reported fiscal 2025 results with net revenue $18.8M (up 33% YoY) and fourth-quarter revenue of $4.7M (up 22% YoY). The company reported net income $1.2M and Adjusted EBITDA $1.6M for 2025, and ended the year with $5.4M cash and no debt.
Gross margin held at 62% for the year; Q4 margin compressed to 58% due largely to tariffs on imports from Italy (15% since April 2025, reduced to 10% Feb 22, 2026). Company cites growth from programmatic reorders, emergency response, service expansion, and a new Nephros Water Institute.
Nephros (Nasdaq: NEPH) will file fourth-quarter 2025 financial results on March 12, 2026 after market close and will host a conference call the same day at 4:30pm ET. Participants can join via domestic and international dial-ins; an audio archive and a replay (through March 19, 2026) will be available on the company's Investor Relations page.
Replay access code: 3018234. Domestic dial-in: 1 (844) 808-7106; international dial-in: 1 (412) 317-5285.
Nephros (Nasdaq: NEPH) announced expansion into Puerto Rico on Feb 13, 2026, targeting medical and commercial water filtration needs.
The company estimates a $10 million Puerto Rico market opportunity across healthcare ($3M), foodservice ($3M), hotels ($1M), other hospitality ($1M) and service contracts/replacements ($1M), and will offer local Spanish support, rapid fulfillment and on-site installation.
Nephros (Nasdaq: NEPH) launched the Nephros Water Institute to formalize and expand its national water-safety education efforts. In 2025 the company reached nearly 1,000 professionals through webinars, national talks, and trainings addressing ASHRAE 514, AAMI ST108, and emergency preparedness.
The Institute will deliver a structured, evidence-based curriculum and a monthly 2026 calendar covering Joint Commission guidance, worker safety at sinks/eyewash stations, construction water-safety links, compounding water quality, federal potable-water expectations, and dialysis water purity.
Nephros (Nasdaq: NEPH) reported third-quarter results for the period ended September 30, 2025, with Q3 net revenue $4.8M (up 35% year-over-year) and Q3 net income $0.3M (up 84% year-over-year), marking the company’s fourth consecutive profitable quarter.
For the nine months ended Sept 30, 2025, net revenue was $14.1M (up 37% YTD) and net income was $1.1M versus a $0.3M loss in prior year; Adjusted EBITDA improved to $1.44M YTD. The company reported cash and equivalents $5.2M and zero debt. Programmatic revenue showed strong growth (Q3 +51%; YTD +35%) and a new PFAS filtration product launched in early October.
Nephros (Nasdaq: NEPH) will file its third-quarter 2025 financial results on Thursday, November 6, 2025 after market close and will host a conference call the same day at 4:30 PM ET.
Participants can join via domestic dial 1 (844) 808-7106 or international dial 1 (412) 317-5285 and should ask to be joined into the Nephros conference call. An audio archive will be posted on the Nephros Investor Relations page shortly after the call.
A replay is available through November 13, 2025 by calling 1 (877) 344-7529 (U.S.) or 1 (412) 317-0088 (international) and entering replay access code 7475880.